ABBOTT LABORATORIES — Director's Dealing 2022

Sep 9, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2022-09-08

Reporting Person: MANNING JOSEPH J (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-09-08	Common shares without par value	M	23008	$44.40	Acquired	76253	Direct
2022-09-08	Common shares without par value	S	23008	$107	Disposed	53245	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-09-08	Option (right to buy)	$44.40	M	23008	Disposed	2027-02-16	Common Shares (23008)	Direct

Footnotes

F1: Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.